CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing new radiopharmaceuticals using isotopes such as Gallium-68 and Technetium-99m for cancer diagnosis and therapy. It aims to enhance targeting efficacy and reduce radiation exposure to non-target organs in nuclear medicine.
Targeted radiopharmaceuticals for diagnosis and therapy are important in the development of a personalised medicinal approach in oncology.
The radiometal isotopes, Ga-68, Tc-99m and Re-188 are particularly useful as they are sourced from a generator and their decay properties are amenable to PET diagnosis, SPECT diagnosis and radiotherapy respectively.
This project aims to develop new radiochemical platforms for these isotopes, expanding their utility in nuclear medicine.
For Tc-99m and Re-188,…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
